C
EBS icon

Covestor’s Emergent Biosolutions EBS Stock Holding History

Covestor’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46K Buy
5,443
+2,737
+101% +$22.9K 0.03% 823
2026
Q1 		$22K Hold
2,706
– – 0.02% 1069
2025
Q4 		$33K Sell
2,706
-1,305
-33% -$14K 0.02% 1059
2025
Q3 		$35K Sell
4,011
-17
-0.4% -$132 0.02% 1061
2025
Q2 		$26K Buy
4,028
+140
+4% +$801 0.02% 1145
2025
Q1 		$19K Buy
3,888
+942
+32% +$7.8K 0.01% 1213
2024
Q4 		$28K Buy
2,946
+2,893
+5,458% +$26.5K 0.02% 1060
2024
Q3 		$0 Sell
53
-25
-32% -$227 ﹤0.01% 2327
2024
Q2 		$0 Buy
78
+52
+200% +$224 ﹤0.01% 2338
2024
Q1 		$0 Sell
26
-1
-4% -$2 ﹤0.01% 2337
2023
Q4 		$0 Buy
27
+14
+108% +$33 ﹤0.01% 2251
2023
Q3 		$0 Buy
13
+8
+160% +$44 ﹤0.01% 2227
2023
Q2 		$0 Sell
5
-1
-17% -$9 ﹤0.01% 2237
2023
Q1 		$0 Hold
6
– – ﹤0.01% 2141
2022
Q4 		$0 Hold
6
– – ﹤0.01% 2174
2022
Q3 		$0 Sell
6
-1,839
-100% -$51.2K ﹤0.01% 2120
2022
Q2 		$57K Buy
1,845
+233
+14% +$7.96K 0.05% 691
2022
Q1 		$66K Buy
1,612
+491
+44% +$21.7K 0.04% 703
2021
Q4 		$49K Buy
+1,121
New +$50.7K 0.07% 551

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Covestor's EBS Position: Q2 2026 in Review

Covestor increased its Emergent Biosolutions (EBS) stake by 101% in Q2 2026, buying an estimated $22.9K and bringing the position to 5,443 shares worth $46K. The position accounts for 0.03% of the portfolio, ranked #823.

Covestor first reported a position in EBS in Q4 2021 and has held it in 19 quarters since. The position peaked at $66K in Q1 2022. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Covestor held 5,443 shares of Emergent Biosolutions worth $46K as of Q2 2026.
  • Covestor bought 2,737 Emergent Biosolutions shares in Q2 2026, an estimated $22.9K.
  • Emergent Biosolutions made up 0.03% of Covestor's portfolio in Q2 2026, its #823 holding.
  • Covestor first reported a position in Emergent Biosolutions in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Emergent Biosolutions position peaked at $66K in Q1 2022.
  • 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.